Peramivir Approval Status

  • FDA approved: No
  • Generic name: peramivir
  • Company: BioCryst Pharmaceuticals, Inc.
  • Treatment for: Influenza

Peramivir is an intravenously administered anti-viral agent in development for the treatment of influenza, including H7N9 and pandemic H1N1 swine flu viral strains.

FDA Approval Status for peramivir

DateArticle
Feb 25, 2014BioCryst Announces Peramivir NDA Acceptance by the FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)